Localization and upregulation of survivin in cancer health disparities: a clinical perspective

Salma Khan,1,2 Heather Ferguson Bennit,1,2 Malyn May Asuncion Valenzuela,1,2 David Turay,1,3 Carlos J Diaz Osterman,1,2 Ron B Moyron,1,2 Grace E Esebanmen,1,2 Arjun Ashok,1,2 Nathan R Wall1,2 1Department of Biochemistry, 2Center for Health Disparities and Molecular Medicine, 3Department of Anatomy,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Khan S, Ferguson Bennit H, Asuncion Valenzuela MM, Turay D, Diaz Osterman CJ, Moyron RB, Esebanmen GE, Ashok A, Wall NR
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/e50eb269141f4d299d10cae8a1a3ab41
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e50eb269141f4d299d10cae8a1a3ab41
record_format dspace
spelling oai:doaj.org-article:e50eb269141f4d299d10cae8a1a3ab412021-12-02T05:49:16ZLocalization and upregulation of survivin in cancer health disparities: a clinical perspective1177-5491https://doaj.org/article/e50eb269141f4d299d10cae8a1a3ab412015-07-01T00:00:00Zhttp://www.dovepress.com/localization-and-upregulation-of-survivin-in-cancer-health-disparities-peer-reviewed-article-BTThttps://doaj.org/toc/1177-5491Salma Khan,1,2 Heather Ferguson Bennit,1,2 Malyn May Asuncion Valenzuela,1,2 David Turay,1,3 Carlos J Diaz Osterman,1,2 Ron B Moyron,1,2 Grace E Esebanmen,1,2 Arjun Ashok,1,2 Nathan R Wall1,2 1Department of Biochemistry, 2Center for Health Disparities and Molecular Medicine, 3Department of Anatomy, Loma Linda University School of Medicine, Loma Linda, CA, USA Abstract: Survivin is one of the most important members of the inhibitors of apoptosis protein family, as it is expressed in most human cancers but is absent in normal, differentiated tissues. Lending to its importance, survivin has proven associations with apoptosis and cell cycle control, and has more recently been shown to modulate the tumor microenvironment and immune evasion as a result of its extracellular localization. Upregulation of survivin has been found in many cancers including breast, prostate, pancreatic, and hematological malignancies, and it may prove to be associated with the advanced presentation, poorer prognosis, and lower survival rates observed in ethnically diverse populations. Keywords: survivin, cancer, exosomes, health disparityKhan SFerguson Bennit HAsuncion Valenzuela MMTuray DDiaz Osterman CJMoyron RBEsebanmen GEAshok AWall NRDove Medical PressarticleMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol 2015, Iss default, Pp 57-67 (2015)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Khan S
Ferguson Bennit H
Asuncion Valenzuela MM
Turay D
Diaz Osterman CJ
Moyron RB
Esebanmen GE
Ashok A
Wall NR
Localization and upregulation of survivin in cancer health disparities: a clinical perspective
description Salma Khan,1,2 Heather Ferguson Bennit,1,2 Malyn May Asuncion Valenzuela,1,2 David Turay,1,3 Carlos J Diaz Osterman,1,2 Ron B Moyron,1,2 Grace E Esebanmen,1,2 Arjun Ashok,1,2 Nathan R Wall1,2 1Department of Biochemistry, 2Center for Health Disparities and Molecular Medicine, 3Department of Anatomy, Loma Linda University School of Medicine, Loma Linda, CA, USA Abstract: Survivin is one of the most important members of the inhibitors of apoptosis protein family, as it is expressed in most human cancers but is absent in normal, differentiated tissues. Lending to its importance, survivin has proven associations with apoptosis and cell cycle control, and has more recently been shown to modulate the tumor microenvironment and immune evasion as a result of its extracellular localization. Upregulation of survivin has been found in many cancers including breast, prostate, pancreatic, and hematological malignancies, and it may prove to be associated with the advanced presentation, poorer prognosis, and lower survival rates observed in ethnically diverse populations. Keywords: survivin, cancer, exosomes, health disparity
format article
author Khan S
Ferguson Bennit H
Asuncion Valenzuela MM
Turay D
Diaz Osterman CJ
Moyron RB
Esebanmen GE
Ashok A
Wall NR
author_facet Khan S
Ferguson Bennit H
Asuncion Valenzuela MM
Turay D
Diaz Osterman CJ
Moyron RB
Esebanmen GE
Ashok A
Wall NR
author_sort Khan S
title Localization and upregulation of survivin in cancer health disparities: a clinical perspective
title_short Localization and upregulation of survivin in cancer health disparities: a clinical perspective
title_full Localization and upregulation of survivin in cancer health disparities: a clinical perspective
title_fullStr Localization and upregulation of survivin in cancer health disparities: a clinical perspective
title_full_unstemmed Localization and upregulation of survivin in cancer health disparities: a clinical perspective
title_sort localization and upregulation of survivin in cancer health disparities: a clinical perspective
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/e50eb269141f4d299d10cae8a1a3ab41
work_keys_str_mv AT khans localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective
AT fergusonbennith localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective
AT asuncionvalenzuelamm localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective
AT turayd localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective
AT diazostermancj localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective
AT moyronrb localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective
AT esebanmenge localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective
AT ashoka localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective
AT wallnr localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective
_version_ 1718400265398255616